頁籤選單縮合
題 名 | 免疫抑制劑與移植後癌症的風險=Risk of Malignancy in Post Organ Transplantation and Using Immunosuppressive Agents |
---|---|
作 者 | 陳文皇; 李亞倫; 陳培亮; 朱賢義; | 書刊名 | 藥學雜誌 |
卷 期 | 30:1=118 2014.03[民103.03] |
頁 次 | 頁86-90 |
分類號 | 418.29 |
關鍵詞 | 器官移植; 免疫抑制劑; 癌症; 卡波西氏肉瘤; Calcineurin inhibitors; Sirolimus; |
語 文 | 中文(Chinese) |
中文摘要 | 器官移植患者需長期服用免疫抑制劑以預防移植器官的排斥反應,病人需面對伴隨而來的藥品副作用及免疫抑制的影響,研究指出術後罹患癌症的風險高於一般非移植族群,由於不同類的免疫抑制劑對於移植後發生癌症的影響並不相同,因此移植前後除了注意癌症的篩檢外,移植後還要慎選免疫抑制劑及注意各免疫抑制劑使用期間與劑量,以降低這些藥品的不良反應。 |
英文摘要 | Organ transplant recipients who need long-term use of immunosuppressive agents to prevent the transplanted organ to be rejected might face upon not only the adverse drug effects but also the risk of malignancy. Furthermore , the risk is higher than in non-organ transplanted general populations. Due to different types of immunosuppressive agents have different risk of cancer formation even with careful cancer screening prior to transplantation, we must carefully select immunosuppressants in order not only to reduce the incidence of malignancy but also to reduce the adverse reactions of these drugs. |
本系統中英文摘要資訊取自各篇刊載內容。